A nonrandomized study of single oral supplementation within the daily tolerable upper level of nicotinamide affects blood nicotinamide and NAD+ levels in healthy subjects-Reference-Cited by-同舟云学术

A nonrandomized study of single oral supplementation within the daily tolerable upper level of nicotinamide affects blood nicotinamide and NAD+ levels in healthy subjects

Published:2020 Issue: Volume:4 Page:45-54
ISSN:2468-5011
Container-title:Translational Medicine of Aging
language:en
Short-container-title:Translational Medicine of Aging

Author:

Ito Takashi K.^ORCID,Sato Tomohito,Hakamata Akio,Onoda Yuki,Sato Shumpei,Yamazaki Fumiyoshi,Horikawa Makoto^ORCID,Takahashi Yutaka,Kitamoto Takuya,Suzuki Masako,Uchida Shinya,Odagiri Keiichi,Setou Mitsutoshi

Funder

Clinical Research at Hamamatsu University Hospital and Advanced Research Facilities and Services at Hamamatsu University School of Medicine

MEXT

JSPS KAKENHI

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Neurology,Geriatrics and Gerontology,Ageing,Physiology

Reference48 articles.

1. Longevity and aging;Kaeberlein;F1000Prime Rep.,2013